MedTrace Logo

Effectiveness of the Quotient® ADHD Assessment in a System of Care

NCT02094612 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 207

Last updated 2017-07-17

Study results available
· View outcomes & findings →

Summary

The study goal is to examine whether the use of an objective computerized neuroassessment (the Quotient System) for Attention-Deficit/Hyperactivity Disorder (ADHD) is related to improved outcomes among pediatric patients being assessed and treated for ADHD.

Conditions

  • Attention Deficit and Disruptive Behavior Disorders
  • Attention Deficit Disorder With Hyperactivity

Interventions

DEVICE

Quotient®

Patients will be randomized once at the time of ADHD assessment to either usual clinic ADHD care or usual clinic ADHD care plus the Quotient using computer-generated random numbers.

BEHAVIORAL

Usual Clinic ADHD Care

Usual ADHD care as provided by the clinic

Sponsors & Collaborators

  • Pearson/Clinical Assessment

    collaborator INDUSTRY

  • Kaiser Permanente

    lead OTHER

Principal Investigators

  • Cynthia I Campbell, PhD · Kaiser Permanente

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Years
Max Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2015-08-31
Completion
2015-08-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02094612 on ClinicalTrials.gov